应用质粒分析探讨医院内细菌感染的流行病学特点

为探讨医院内细菌感染的流行病学特点，作者借助临床分离的６４株肺为克雷伯菌，４５株阴沟肠杆菌和６３株醋酸钙不动杆菌，进行质粒图谱分３种细菌分别有５８株，３５株和４１株含有质粒，且分别构成４６个，２１个和２３个质粒图谱型。结果表明：质粒分析为查明医院内细菌感染源和感染途径提供了较为直接，准确的客观依据，同时也看到了质粒分析的局限性。     

浅谈对传染科护士素质的要求与体会

根据笔者在传染科病房工作中的体会,从六个方面针对传染科工作的特殊性和存在的共性分别阐述了传染科护士在工作中如何高标准、严要求自己,如何对病人做到到位的护理,旨在提高传染科病房的整体护理质量,从而把更多的实惠让利于患者。     

30例急性单发性球形肺炎的临床与CT特点

目的　通过分析 3 0例急性单发性球形肺炎的临床与CT特点 ,提高与周围性肺癌的鉴别能力。方法　对 3 0例住院患者 ,入院后均行胸片、胸部CT、纤维支气管镜检查及痰涂片、痰细菌培养等检查。结果　痰细菌培养均为细菌感染 ,胸片、胸部CT显示病灶为贴近胸膜或沿支气管血管束分布占 70 .0 0 % ;分布在两肺下叶背段或后基底段占 60 .0 0 %。病灶直径 2 .0～ 4.5cm 2 4例 ,占 80 .0 0 % ,2 5例患者经抗炎治疗病灶完全吸收。结论　抗炎治疗是动态观察单发性球形肺炎病灶变化的一种有效方法。     

The child with recurrent respiratory infections: normal or not?

Respiratory infections (RI) are one of the major complaints in children and adolescents, and represent a demanding challenge for the pediatrician. It has been estimated that at least 6% of Italian children younger than 6 yr of age present recurrent respiratory infections (RRI). Children with RRI are not affected by severe alterations of the immune system. RRI represent essentially the consequence of an increased exposure to infectious agents during the first years of life, when immune functions are still largely immature. Several social and environmental factors, such as day-care attendance, family size, air pollution, parental smoking, and home dampness, represent important risk factors for airway diseases and may contribute in various degrees to determine the incidence of RRI. The main problem for the pediatrician is to discriminate normal children with high RI frequency related to an augmented exposure to environmental risk factors from children affected by other underlying pathological conditions (immunological or not), predisposing to infectious diseases. When RRI diagnosis has been formulated, removal of environmental risk factors (i.e. precocious day-care attendance, smoking in the household) must first be suggested.     

The epidemiology of nosocomial Pseudomonas cepacia infections: Endemic infections

Pseudomonas cepacia has recently emerged as an important nosocomial pathogen. We analyzed a national nosocomial infections database, the National Nosocomial Infections Surveillance (NNIS) system, to describe the epidemiology of endemic nosocomial P. cepacia infections. Between 1980 and 1985, the P. cepacia nosocomial infection rate was 2.4 per 100,000 patient discharges. During this period, there was a significant increase in the P. cepacia infection rate. The highest infection rate was reported from large medical school-affiliated hospitals. Over 90% of the infections were reported from medicine and surgery services. The most frequently reported site of infection was the lower respiratory tract (31%), followed by blood (20%) and the urinary tract (20%). Nosocomial P. cepacia infections are often associated with mortality, particularly when they involve the lung. These data confirm the hypothesis that P. cepacia is an emerging nosocomial pathogen and suggest that the epidemiology of endemic infections differs from that reported for epidemic inflections.     

Epidemiological considerations following long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1992–2003

A nationwide laboratory-based surveillance system for invasive group A streptococcal (GAS) infections was conducted in The Netherlands from March 1992 until December 2003. Until 1996, all isolates submitted were evaluated clinically and demographically. During this period there was a transition from passive to active surveillance for some of the participating laboratories, corresponding to a national coverage of 50%. During active surveillance, participating laboratories submitted twice as many isolates from invasive GAS disease, whereas the relative submission of isolates representing very severe manifestations (toxic shock-like syndrome, fatality) did not increase. From 1997 onwards, invasiveness was defined solely on the basis of source of isolation (without clinical evaluation). During the period of microbiological and clinical evaluation, microbiological evaluation alone was found to be specific (> 99%), but had limited sensitivity (66%). Estimation of the true rate of invasive GAS disease should be based on an active surveillance system with inclusion of both microbiological and clinical data.     

肺炎衣原体抗体效价与多发性硬化的相关性探讨

目的 探讨肺炎衣原体（Chlamydia pneumoniae）感染在多发性硬化（MS）发病和进展中的作用和致病机制。方法 选取急性期MS患者31例，缓解期MS患者28例及其他神经系统疾病患者30例，健康对照者30名，应用酶联免疫吸附试验测定患者和对照者血清及脑脊液中肺炎衣原体IgG和IgM抗体水平。结果 急性期MS组、缓解期MS组、其他神经系统疾病组和健康对照组的肺炎衣原体血清IgG分别为48．4％、35．7％、30．0％、23．3％；4组IgM抗体效价分别为12．9％、14．3％、20．0％、10．0％，总体比较差异无统计学意义（P〉0．05）；急性期MS组与其他神经系统疾病组的脑脊液IgG和IgM抗体效价分别为0、6．7％和0、0，差异无统计学意义（P〉0．05）。结论 肺炎衣原体的感染或重复感染与MS发病相关不紧密，可能仅为MS的伴随感染。     

消化性溃疡病因分析

[目的]探讨幽门螺旋杆菌感染和非甾体类消炎药应用与消化性溃疡的关系．[方法]对1062例消化不良患者进行内窥镜检壹、快速尿素酶实验和血清抗幽门螺旋杆菌免疫球蛋白检验，同时记录非甾体类消炎药的应用情况，计算消化不良患者消化性溃疡发病事、幽门螺旋杆菌感染率及非甾体类消炎药应用率．[结果]溃疡发病率为29．3％，幽门螺旋杆菌感染串为37．2％，非甾体类消炎药使用率为10．0％．[结论]幽门螺旋杆菌及非甾体类消炎药相互作用干上消化道黏膜．是引发消化性溃疡的重要病因．     

N-乙酰半胱氨酸的抗菌活性及对细菌生物被膜的抑制作用

N-乙酰半胱氨酸(N-acetylcysteine,NAC)是临床常用化痰药.除此之外,NAC还有一定的抗菌活性,可以抑制细菌的黏附,减少细胞外多糖蛋白复合物的产生,破坏已生成的生物被膜,对被膜下细菌也有一定的杀菌作用,并与某些抗菌药物存在协同作用,引起国内外学者越来越多的关注.研究结果提示临床上可以将NAC与抗生素联合应用治疗某些感染性疾病尤其是慢性呼吸道感染,不过尚需进一步大样本临床研究来证明.     

阿奇霉素和鱼腥草治疗小儿下呼吸道感染

目的　探讨静脉点滴阿奇霉素和鱼腥草治疗小儿下呼吸道感染的临床疗效及其安全性。方法　采用随机对照分组研究 ,观察组使用阿奇霉素 5～ 10mg/kg ,每日 1次 ,加鱼腥草 1～ 3ml/ (kg·d) ,每日 1次静脉滴注 ,疗程 5～ 7d。对照组选用头孢拉定 5 0～ 10 0mg/ (kg·d)加利巴韦林 10mg/ (kg·d)静脉滴注 ,每日 2次 ,疗程 5～ 7d。结果　观察组痊愈率和有效率分别为 72 .5 %和 89.8% ,而对照组的痊愈率和有效率分别为 4 5 .3%和 73.6 % (P <0 .0 1) ,观察组和对照组的不良反应发生率分别为 13.5 %和 10 .8% (P >0 .0 5 )。结论　阿奇霉素加鱼腥草静脉滴注治疗小儿下呼吸道感染临床疗效确切 ,不良反应较少